These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

802 related items for PubMed ID: 10613655

  • 1. The fibrinogen gamma chain dodecapeptide inhibits agonist-induced aggregation of rabbit platelets and fibrinogen binding to rabbit glycoprotein IIb-IIIa.
    Rand ML, Packham MA, Taylor DM, Yeo EL, Gemmell CH, Patil S, Lam SC.
    Thromb Haemost; 1999 Dec; 82(6):1680-6. PubMed ID: 10613655
    [Abstract] [Full Text] [Related]

  • 2. [Conformational changes of the platelet membrane glycoprotein IIb-IIIa complex stimulated by a monoclonal antibody to the N-terminal segment of glycoprotein IIIa].
    Khaspekova SG, Vyzova TV, Lukin VV, Tikhomirov OIu, Berndt M, Kouns W, Mazurov AV.
    Biokhimiia; 1996 Mar; 61(3):412-28. PubMed ID: 8724599
    [Abstract] [Full Text] [Related]

  • 3. Ultrastructural analysis of thrombin-induced interaction between human platelets and liposomes carrying fibrinogen γ-chain dodecapeptide as a synthetic platelet substitute.
    Suzuki H, Okamura Y, Ikeda Y, Takeoka S, Handa M.
    Thromb Res; 2011 Dec; 128(6):552-9. PubMed ID: 21840573
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Functional characterization of PM6/13, a beta3-specific (GPIIIa/CD61) monoclonal antibody that shows preferential inhibition of fibrinogen binding over fibronectin binding to activated human platelets.
    Patel Y, Rahman S, Siddiqua A, Wilkinson JM, Kakkar VV, Authi KS.
    Thromb Haemost; 1998 Jan; 79(1):177-85. PubMed ID: 9459345
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Prevention of platelet glycoprotein IIb/IIIa activation by 3,4-methylenedioxy-beta-nitrostyrene, a novel tyrosine kinase inhibitor.
    Wang WY, Wu YC, Wu CC.
    Mol Pharmacol; 2006 Oct; 70(4):1380-9. PubMed ID: 16837624
    [Abstract] [Full Text] [Related]

  • 8. The interaction of disagregin with the platelet fibrinogen receptor, glycoprotein IIb-IIIa.
    Karczewski J, Connolly TM.
    Biochem Biophys Res Commun; 1997 Dec 29; 241(3):744-8. PubMed ID: 9434779
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of fibrinogen binding and surface recruitment of GpIIb/IIIa as dose-dependent effects of the RGD-mimetic MK-852.
    Wittig K, Rothe G, Schmitz G.
    Thromb Haemost; 1998 Mar 29; 79(3):625-30. PubMed ID: 9531053
    [Abstract] [Full Text] [Related]

  • 10. Characterization of human platelet IgG Fc receptor associated with membrane glycoprotein.
    Shido K, Ahmad G, Hsu L, Kamiyama M.
    J Clin Lab Immunol; 1995 Mar 29; 46(1):1-11. PubMed ID: 9363587
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A defined peptide that inhibits the formation of the glycoprotein IIb and IIIa complex.
    Chiang TM, Zhu J.
    Thromb Res; 2005 Mar 29; 115(6):503-8. PubMed ID: 15792682
    [Abstract] [Full Text] [Related]

  • 15. Platelet aggregation and fibrinogen binding in human, rhesus monkey, guinea-pig, hamster and rat blood: activation by ADP and a thrombin receptor peptide and inhibition by glycoprotein IIb/IIIa antagonists.
    Cook NS, Zerwes HG, Tapparelli C, Powling M, Singh J, Metternich R, Hagenbach A.
    Thromb Haemost; 1993 Sep 01; 70(3):531-9. PubMed ID: 8259560
    [Abstract] [Full Text] [Related]

  • 16. Triflavin, an antiplatelet Arg-Gly-Asp-containing peptide, is a specific antagonist of platelet membrane glycoprotein IIb-IIIa complex.
    Huang TF, Sheu JR, Teng CM, Chen SW, Liu CS.
    J Biochem; 1991 Feb 01; 109(2):328-34. PubMed ID: 1864844
    [Abstract] [Full Text] [Related]

  • 17. Hemostatic effects of phospholipid vesicles carrying fibrinogen gamma chain dodecapeptide in vitro and in vivo.
    Okamura Y, Maekawa I, Teramura Y, Maruyama H, Handa M, Ikeda Y, Takeoka S.
    Bioconjug Chem; 2005 Feb 01; 16(6):1589-96. PubMed ID: 16287259
    [Abstract] [Full Text] [Related]

  • 18. Antiplatelet efficacy of XV459, a novel nonpeptide platelet GPIIb/IIIa antagonist: comparative platelet binding profiles with c7E3.
    Mousa SA, Bozarth JM, Lorelli W, Forsythe MS, Thoolen MJ, Slee AM, Reilly TM, Friedman PA.
    J Pharmacol Exp Ther; 1998 Sep 01; 286(3):1277-84. PubMed ID: 9732389
    [Abstract] [Full Text] [Related]

  • 19. Differential inhibition of fibrinogen binding to agonist- and RGDS peptide-activated states of GPIIb-IIIa by an anti-GPIIIa monoclonal antibody, PMA5.
    Nakatanl S, Hato T, Minamoto Y, Fujita S.
    Thromb Haemost; 1996 Dec 01; 76(6):1030-7. PubMed ID: 8972028
    [Abstract] [Full Text] [Related]

  • 20. Modulation of platelet-neutrophil interaction with pharmacological inhibition of fibrinogen binding to platelet GPIIb/IIIa receptor.
    Xiao Z, Théroux P, Frojmovic M.
    Thromb Haemost; 1999 Feb 01; 81(2):281-5. PubMed ID: 10064007
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.